H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 4, 1997, Pages 729-734

  Meining, A ^a   Bosseckert, H ^b   Caspary, W F ^c   Nauert, C ^d   Stolte, M ^e  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d Rhone Poulenc Rorer GmbH   (Germany)

^e INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; RANITIDINE; UREA; ALUMINUM HYDROXIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; MAGNESIUM HYDROXIDE;

ARTICLE; BIOPSY; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; GASTRITIS; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; COMPARATIVE STUDY; DRUG EFFECT; HELICOBACTER INFECTION; PATHOLOGY; STOMACH;

ALUMINUM HYDROXIDE; ANTACIDS; DOUBLE-BLIND METHOD; DUODENAL ULCER; GASTRITIS; HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS; HUMANS; MAGNESIUM HYDROXIDE; RANITIDINE; STOMACH;

EID: 0030612463     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00196.x     Document Type: Article

References (31)

1. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 705-8.
2. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.
3. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up. Lancet 1994; 343: 258-60.
4. Bayerdörffer E, Miehlke S, Lehn N, et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German gastric ulcer study. Eur J Gastroenterol Hepatol 1996; 8: 343-9.
5. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. New Engl J Med 1995; 332: 139-42.
6. Buckley M, O'Morain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia. Aliment Pharmacol Ther 1995; 9 (Suppl. 2): 53-8.
7. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-83.
8. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or funduplication. N Engl J Med 1996; 334: 1018-22.
9. Logan RPH, Walker MM, Misiewicz JJ, Gummet PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-6.
10. Solcia E, Villani L, Fiocca R, et al. Effect of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 29 (Suppl. 201): 28-34.
11. Stolte M, Bethke B. Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 1990; 28: 271-4.
12. Bosseckert H, Caspary WF, Stolte M, Nauert C. Niedrig dosierte Antacidatherapie zur Behandlung des Ulcus duodeni. Verdanungskrankheiten 1996; 14(2): 50-5.
13. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
14. Stolte M, Stadelmann O, Bethke B, Burkhard G. Relationship between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol 1995; 33: 89-93.
15. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long-term treatment with omeprazole for refractory reflex esophagitis: efficacy and safety. Ann Intern Med 1994; 121: 161-7.
16. Lamberts R, Creutzfeldt W, Strüber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104: 1356-70.
17. Geboes K, Ectors N, Penson J, Leuven KU. Long-term lansoprazole treatment in man: effects on gastric mucosa histology. Gastroenterology 1995; 108: A99 (Abstract).
18. Stolte M, Bethke B, Blum AL, Sulser E, Stadelmann O. Antacid treatment has a deleterious effect on the severity and activity of gastritis of the corpus mucosa. Ir J Med Sc 1992; 161(Suppl. 10): 6(Abstract).
19. Madsen JE, Vetvik K, Aase S. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent. Scand J Gastroenterol 1991; 26: 465-70.
20. Lage AP, Glupczynski Y. Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negative Helicobacter pylori strains and does not inhibit vacuolating toxin produetion. Eur J Gastroenterol Hepatol 1994; 6: 299-301.
21. Vogt K, Hahn H. Influence of omeprazole on urease activity of Helicobacter pylori in vitro. Zbl Bakt 1993; 280: 272-8.
22. Jönsson KÄ, Ström M, Bodemar G, Norrby K. Histological changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988; 23: 433-41.
23. Roland M, Berstad A, Liavåg I. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol 1975; 10: 181-6.
24. Sipponen P, Kekki M, Seppälä K, Siurala M. The relationship between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996: 10(Suppl. 1): 103-8.
25. Lee A, Dixon MF, Danon SJ, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-5.
26. Penston JG. Clinical assessment, gastrin concentration, and gastric histology after 5 years of maintenance treatment with ranitidine for duodenal ulcers. Scand J Gastroenterol 1991; 25(Suppl. 177): 77-86.
27. Eidt S, Stolle M. Antral metaplasia in Helicobacter pylori gastritis. Digestion 1994; 55: 13-8.
28. Meining A, Stolte M, Lehn N, et al. Differing expression of gastritis in Helicobacter pylori associated diseases. Gastroenterology 1996; 110: A193 (Abstract).
29. Eidt S, Stolte M. Differences between Helicobacter pylori associated gastritis in patients with duodenal ulcer, pyloric ulcer, other gastric ulcer, and gastritis without ulcer. In: Malfertheiner P, Ditschuneit H, eds. Gastritis and Peptic Ulcer. Berlin, Heidelberg: Springer, 1990: 228-56.
30. Genta M. Helicobacter pylori as a promotor of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): 25-30.
31. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994; 6(Suppl. 1): 79-83.